How modifications to proteins lead to Parkinson's Disease

Add to your list(s) Download to your calendar using vCal

• Alex van der Wateren
• Thursday 25 April 2013, 13:10-14:00
• 1 Newnham Terrace, Darwin College.

If you have a question about this talk, please contact Sven Friedemann.

Parkinson’s disease is a neurodegenerative disease characterized by inclusions of a small intrinsically disordered protein (14 kDa), α‐synuclein (AS) in Lewy Bodies. Modifications to AS, such as point mutations (A30P, A53T , E46K), phosphorylation of Tyrosine 125 and Serine 129, N-terminal acetylation as well as C‐terminal truncations might affect functioning of the protein as well as its aggregation behaviour into amyloid fibrils. However, detailed mechanistic understanding of the molecular events that lead to the conversion of soluble protein into insoluble aggregates is currently lacking for AS. I will give a short introduction to neurodegenerative diseases in general and explain how my research aims to elucidate the mechanisms that operate in Parkinson’s Disease.

This talk is part of the Darwin College Science Seminars series.

This talk is included in these lists:

• 1 Newnham Terrace, Darwin College
• AUB_Cambridge Seminars
• All Talks (aka the CURE list)
• Centre for Health Leadership and Enterprise
• Chris Davis' list
• Darwin College Research Talks
• Darwin College Science Seminars
• Darwin Lectures and Seminars
• Guy Emerson's list
• Interested Talks
• Neurons, Fake News, DNA and your iPhone: The Mathematics of Information
• custom

Note that ex-directory lists are not shown.